PSNL
Personalis, Inc.NASDAQHealthcare$6.58+0.30%ClosedMarket Cap: $584.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.32
P/S
8.39
EV/EBITDA
-6.92
DCF Value
$1.13
FCF Yield
-13.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
22.7%
Operating Margin
-126.4%
Net Margin
-116.7%
ROE
-39.1%
ROA
-24.3%
ROIC
-29.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $17.3M | 11.0% | $-25.3M | $-23.8M | $-0.26 | — |
| FY 2025 | $0.00 | -Infinity% | $-88.1M | $-81.3M | $-0.91 | — |
| Q3 2025 | $14.5M | 13.2% | $-23.3M | $-21.7M | $-0.24 | — |
| Q2 2025 | $17.2M | 27.6% | $-21.8M | $-20.1M | $-0.23 | — |
| Q1 2025 | $20.6M | 35.0% | $-17.7M | $-15.8M | $-0.18 | — |
| Q4 2024 | $16.8M | 27.1% | $-18.1M | $-16.4M | $-0.23 | — |
| FY 2024 | $84.6M | 31.7% | $-68.3M | $-81.3M | $-1.37 | — |
| Q3 2024 | $25.7M | 34.0% | $-14.4M | $-39.1M | $-0.64 | — |
| Q2 2024 | $22.6M | 35.6% | $-16.9M | $-12.8M | $-0.24 | — |
| Q1 2024 | $19.5M | 28.1% | $-18.9M | $-13.0M | $-0.26 | — |
| Q4 2023 | $19.7M | 26.5% | $-24.0M | $-26.6M | $-0.54 | — |
| FY 2023 | $73.5M | 24.8% | $-109.9M | $-108.3M | $-2.25 | — |